Examples of 'increase plasma concentrations' in a sentence
Meaning of "increase plasma concentrations"
Increase plasma concentrations refers to the act of raising the levels of certain substances in the blood plasma. This can be achieved through various methods, such as medication or lifestyle changes. It is often used in medical and scientific contexts to describe the desired effect of a treatment or intervention
How to use "increase plasma concentrations" in a sentence
Basic
Advanced
increase plasma concentrations
Etravirine is expected to increase plasma concentrations of diazepam.
May increase plasma concentrations of.
Avoid grapefruit or grapefruit juice which may increase plasma concentrations of crizotinib.
Dronedarone could increase plasma concentrations of immunosupressants tacrolimus, sirolimus, everolimus and cyclosporine.
Coadministration of nelfinavir with fluticasone proprionate may increase plasma concentrations of fluticasone propionate.
Kaletra is likely to increase plasma concentrations of medicinal products that are primarily.
Concomitant use of bosentan and boosted darunavir may increase plasma concentrations of bosentan.
Doxycycline can increase plasma concentrations of cyclosporine.
Concomitant use of salmeterol and boosted darunavir may increase plasma concentrations of salmeterol.
Dolutegravir may increase plasma concentrations of medical products in which excretion is dependent upon OAT3.
Based on theoretical considerations boosted darunavir may increase plasma concentrations of these analgesics.
Dolutegravir may increase plasma concentrations of medicinal products in which excretion is dependent upon OAT3.
Concomitant systemic use of itraconazole or ketoconazole and etravirine may increase plasma concentrations of etravirine.
Boosted PREZISTA may increase plasma concentrations of prednisone.
Concomitant use of voriconazole and INTELENCE may increase plasma concentrations of both drugs.
See also
Darunavir may increase plasma concentrations of prednisone . CYP3A inhibition.
Based on theoretical considerations REZOLSTA may increase plasma concentrations of these analgesics.
Brivaracetam may increase plasma concentrations of medicinal products metabolised by CYP2C19 e.g. lanzoprazole, omeprazole, diazepam.
Concomitant use of trazodone and VIRACEPT may increase plasma concentrations of trazodone.
Brivaracetam 200mg/day may increase plasma concentrations of medicinal products transported by OAT3.
Bodybuilders also try to buy them. They are noted to increase plasma concentrations of:.
Etravirine is expected to increase plasma concentrations of warfarin.
Grapefruit juice contains an inhibitor of CYP3A4 and may also increase plasma concentrations of pazopanib.
Fluoxetine and paroxetine increase plasma concentrations of risperidone.
Concomitant use of P-gp inhibitors such as cyclosporine may increase plasma concentrations of naldemedine.
Similarly, valaciclovir administration may increase plasma concentrations of the concurrently administered substance.
Co-administration of ciclosporin, a potent P-gp inhibitor, is expected to increase plasma concentrations of tenofovir alafenamide.
Inhibitors of CYP3A4 increase plasma concentrations of ranolazine.
Concomitant use of bosentan and boosted PREZISTA may increase plasma concentrations of bosentan.
Letermovir may substantially increase plasma concentrations of these statins.
Concomitant use of fluticasone propionate and VIRACEPT may increase plasma concentrations of fluticasone propionate.
INTELENCE is expected to increase plasma concentrations of warfarin.
Not studied, etravirine is expected to increase plasma concentrations of diazepam.
Co-administration of fluconazole or isavuconazole may increase plasma concentrations of tenofovir alafenamide.
Carriers of genetic polymorphisms that may increase plasma concentrations of statins ;.
Co-administration of ketoconazole is expected to increase plasma concentrations of tenofovir alafenamide inhibition of P-gp.
Based on theoretical considerations DRV / COBI may increase plasma concentrations of these analgesics.
Posaconazole, a potent inhibitor of CYP3A4, may increase plasma concentrations of etravirine.
Co-administration of abemaciclib with CYP3A4 inhibitors can increase plasma concentrations of abemaciclib.
Therefore, cabozantinib may have the potential to increase plasma concentrations of co-administered substrates of P-gp.
You'll also be interested in:
Examples of using Plasma
Show more
Plasma concentrations are similar in males and females
Operating the plasma display basic operations
Plasma concentrations were quantifiable in all the patients
Examples of using Concentrations
Show more
Plasma concentrations are similar in males and females
Found in highly elevated concentrations in top predators
Concentrations in volume per cent on wet basis
Examples of using Increase
Show more
You should gradually increase your activity
Increase access to high quality cancer risk
Developing strategies to increase access to all populations
